A Study to Evaluate AZD2693 in Participants Who Are Carriers of the PNPLA3 148M Risk Allele With Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis
PHASE2
A Study to Evaluate the Efficacy, Safety and Tolerability of AZD2693 given ...
A Study to Understand the Safety, Tolerability, and Activity of Drug in Body Over a Period of Time of AZD2693, in Subjects of Non-Childbearing Potential in Overweight But Otherwise Healthy Subjects, and Healthy Chinese and Japanese Subjects
PHASE1
This Phase 1, first-in-human (FiH), single-ascending-dose (SAD) study, will...